This article is more than 5 years old. Information may no longer be current.

Alcon's Pazeo allergy drop available March 10

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ATLANTA – Alcon’s new once daily Pazeo will be commercially available March 10, announced a company representative during a press conference here at SECO.

Mike Burns, U.S. allergy brand manager for Alcon, said that Pazeo (olopatadine HCl ophthalmic solution 0.7%), which the FDA approved Jan. 30, will be available to doctors next week.

He said that two studies demonstrated statistically significant relief of ocular itching associated with allergic conjunctivitis.

Primary Care Optometry News previously reported that the drop provided 24-hour relief of ocular itching.

Burns noted that the drop is not indicated for use with contact lenses.